Overview
TheracosBio is a pharmaceutical company focused on the development and commercialization of innovative therapies for treating diabetes and other metabolic disorders. The company is committed to advancing science through rigorous research and development efforts.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to TheracosBio in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Amylin Pharmaceuticals, LLC
USA
EndocrineHealth Pharmaceuticals Inc.
USA
Global Diabetes Research Organization
United States
National Institute of Diabetes
USA
Advanced Diabetes Supply
United States
Aegerion Pharmaceuticals, Inc.
United States
Alexion Pharmaceuticals, Inc.
United States
BioMarin Pharmaceutical Inc.
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.